Dokumendiregister | Ravimiamet |
Viit | MSO-13/1271-1 |
Registreeritud | 11.03.2025 |
Sünkroonitud | 12.03.2025 |
Liik | Sissetulev kiri |
Funktsioon | MSO Meditsiiniseadmed |
Sari | MSO-13 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus) |
Toimik | MSO-13/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Syneos Health |
Saabumis/saatmisviis | Syneos Health |
Vastutaja | Merili Saar-Abroi (RA, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: "Martello, Daiana" <[email protected]>
Sent: Mon, 10 Mar 2025 11:02:16 +0000
To: "[email protected]" <[email protected]>
Cc: SPVG Regulatory Intelligence <[email protected]>
Subject: Clinical investigations with Medical Devices - Safety reporting email address
Dear Sir/Madam,
I am a Safety Specialist at Syneos Health (Clinical Research Organization), a company responsible for Safety reporting on behalf of Sponsors in the frame of Clinical Investigations with Medical Devices and In Vitro Diagnostics (IVDs).
In the context of the announcement published on 1 January 2025 on the Ravimiamet website (link), we would like to confirm that the email address [email protected] can be used to submit safety reports arising from Clinical Investigations with Medical Devices.
Thanks in advance for your support.
Kind regards,
Daiana
Daiana Martello
Sr Safety & PV Ops Specialist
Syneos Health
Upcoming absence: 17-Apr-2025, 18-Apr-2025, 1-May-2025
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Küsimused | 11.03.2025 | 1 | MSO-13/1271-2 | Väljaminev kiri | ra | Syneos Health |